APA (7th ed.) Citation

Wu, T., Wu, S., Li, L., Xiang, J., Wang, N., Chen, W., & Zhang, J. (2023). The impact of ABCB1, CYP3A4/5 and ABCG2 gene polymorphisms on rivaroxaban trough concentrations and bleeding events in patients with non-valvular atrial fibrillation. BMC.

Chicago Style (17th ed.) Citation

Wu, Tingting, Shuyi Wu, Li Li, Jing Xiang, Na Wang, Wenjun Chen, and Jinhua Zhang. The Impact of ABCB1, CYP3A4/5 and ABCG2 Gene Polymorphisms on Rivaroxaban Trough Concentrations and Bleeding Events in Patients with Non-valvular Atrial Fibrillation. BMC, 2023.

MLA (9th ed.) Citation

Wu, Tingting, et al. The Impact of ABCB1, CYP3A4/5 and ABCG2 Gene Polymorphisms on Rivaroxaban Trough Concentrations and Bleeding Events in Patients with Non-valvular Atrial Fibrillation. BMC, 2023.